Gynaecology
Conducting clinical trials in gynaecology demands deep sensitivity to patient needs and comprehensive understanding of women’s health issues.
Gynaecology clinical trials often involve addressing conditions that significantly impact quality of life and require patient-centred methodologies to ensure comfort, compliance, and accurate data collection. We engage deeply with women’s health specialists, advocacy groups, and patient communities to design and implement studies that are scientifically rigorous yet sensitive to participant experiences.
Common Gynaecology indications in which we have experience include:
- Endometriosis
- Uterine fibroids
- Polycystic Ovary Syndrome (PCOS)
- Menopause and hormonal therapies
Disciplined,
Cost-Efficient Execution
while maintaining the Highest Quality
Local Trials,
Global Approvals
Access FDA Regulatory Expertise
Our Clinical Team has over
120
years
of Combined Clinical Trial Experience
Gynaecology Clinical Trial Resources
Menopausal Insomnia
Overcoming Barriers in Endpoints and Safety to Improve Outcomes in Menopausal Insomnia Clinical Trials
Addressing Common Pain Points Associated with Gynaecology Clinical Trials
Patient Recruitment and Sensitivity
Problem:
Recruiting patients for sensitive gynaecological conditions can be challenging.
iNGENū CRO addresses this pain point with Tailored Recruitment Strategies:
We employ sensitive, patient-centric recruitment approaches, including partnerships with women’s health clinics and advocacy groups, and telemedicine platforms to ensure comfort and engagement.
Subjective Outcome Measures
Problem:
Gynaecological conditions often rely on patient-reported outcomes (PROs), which can introduce variability.
iNGENū CRO addresses this pain point with Standardised PRO Tools:
We implement validated, standardised PRO instruments and provide thorough training to clinical staff, ensuring consistency and accuracy in data collection.
Placebo Effects and Blinding
Problem:
Strong placebo effects can complicate the interpretation of trial results in hormonal treatments.
iNGENū CRO addresses this pain point with Robust Blinding Methods:
We design trials with rigorous blinding procedures and use advanced statistical analyses to account for placebo responses.
Safety Monitoring
Problem:
Hormonal treatments require vigilant safety monitoring for potential adverse effects.
iNGENū CRO addresses this pain point with Comprehensive Safety Protocols:
We utilise advanced monitoring systems and real-time safety reviews to promptly identify and manage adverse events, prioritising patient well-being.
The iNGENū CRO Difference
Local Trials, Global Approvals
We uniquely combine Australian expertise with direct FDA submission capabilities.
Disciplined, Cost-Efficient Execution
iNGENū CRO takes a highly strategic approach to clinical research.
Australian-Headquartered, Asia-Pacific Reach
We provide sponsors with comprehensive trial capabilities.
We have been using iNGENū for a Phase 1, first-in-human trial of our investigational drug. We have been very happy with all aspects of the management of the clinical trial.
Ready to discuss your Gynaecology Clinical Trial?